Exact Mass: 438.1835962
Exact Mass Matches: 438.1835962
Found 352 metabolites which its exact mass value is equals to given mass value 438.1835962
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
8-Propanoylneosolaniol
8-Propanoylneosolaniol is produced by Fusarium sporotrichioides.
Suxibuzone
M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use Suxibuzone is a drug used for joint and muscular pain. It is a prodrug of the non steroidal anti inflammatory drug phenylbutazone, and is commonly used in horses. C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
Turofexorate isopropyl
C25H24F2N2O3 (438.17548980000004)
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent
Sotrastaurin
C25H22N6O2 (438.18041519999997)
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor
9alpha-Acetoxymelnerin A
N-[[3-[3-fluoro-4-[4-[(2H-triazol-4-ylmethylamino)methyl]phenyl]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide
1beta,10beta-epoxy-3alpha-angeloyloxy-9beta-acetoxy-8alpha,11beta-dihydroxybakkenolide
15beta-Acetyl-14-hydroxyklaineanone|15beta-O-acetyl-14-hydroxyklaineanone|15??-O-Acetyl-14-hydroxyklaineanone
(1R*,2R*,3R*,5Z,7S*,8R*,9S*,10S*,11R*,14S*,17R*)-2-acetoxy-8,17-epoxy-3,9,14-trihydroxybriar-5-ene-12,18-dione|excavatolide T
5-Me ester-9-(3-Hydroxy-3-methylglutaroyloxy)-abscisic acid
N-methoxycarbonyl-11,12-methylenedioxy-Delta16,17-kopsinine
1R*-(4-hydroxy-3,5-dimethoxy-phenyl)-2R*-[4-(3-hydroxy-propyl)-2,6-dimethoxy-phenoxy]-propane-1,3-diol|burseneolignan
(-)-threo-4,9,4,9-tetrahydroxy-3,5,7,3-tetramethoxy-8-O-8-neolignan
(-)-threo-4,9,4,9-tetrahydroxy-3,7,3,5-tetramethoxy-8-O-8-neolignan
methyl (4R*,4aR*,5S*,7aS*,8aS*,8bR*)-4,5-bis(acetyloxy)-5-[(acetyloxy)methyl]-4a,5,6,7,7a,8,8a,8b-octahydro-8,8-dimethyl-4H-cyclopropa[3,4]cyclohepta[1,2-c]pyran-1-carboxylate
brasiliamide A|N1,N2-diacetyl-N2-(2-oxo-3-phenylpropyl)-3-(3-methoxy-4,5-methylenedioxyphenyl)-1,2-(Z)-propenediamine
C24H26N2O6_Acetamide, N-[(Z)-2-(acetylamino)-1-[(7-methoxy-1,3-benzodioxol-5-yl)methyl]ethenyl]-N-(2-oxo-3-phenylpropyl)
suxibuzone
M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents CONFIDENCE standard compound; INTERNAL_ID 1135; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4740; ORIGINAL_PRECURSOR_SCAN_NO 4737 CONFIDENCE standard compound; INTERNAL_ID 1135; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4766; ORIGINAL_PRECURSOR_SCAN_NO 4761 CONFIDENCE standard compound; INTERNAL_ID 1135; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4755; ORIGINAL_PRECURSOR_SCAN_NO 4750 CONFIDENCE standard compound; INTERNAL_ID 1135; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4785; ORIGINAL_PRECURSOR_SCAN_NO 4781 CONFIDENCE standard compound; INTERNAL_ID 1135; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4770; ORIGINAL_PRECURSOR_SCAN_NO 4767 CONFIDENCE standard compound; INTERNAL_ID 1135; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9123; ORIGINAL_PRECURSOR_SCAN_NO 9121 CONFIDENCE standard compound; INTERNAL_ID 1135; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9211; ORIGINAL_PRECURSOR_SCAN_NO 9206 CONFIDENCE standard compound; INTERNAL_ID 1135; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9241; ORIGINAL_PRECURSOR_SCAN_NO 9238 CONFIDENCE standard compound; INTERNAL_ID 1135; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9265; ORIGINAL_PRECURSOR_SCAN_NO 9264 CONFIDENCE standard compound; INTERNAL_ID 1135; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9293; ORIGINAL_PRECURSOR_SCAN_NO 9291 CONFIDENCE standard compound; INTERNAL_ID 1135; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9260; ORIGINAL_PRECURSOR_SCAN_NO 9258
Ala Ala Asp Tyr
Ala Ala Tyr Asp
Ala Asp Ala Tyr
Ala Asp Phe Ser
Ala Asp His Pro
Ala Asp Pro His
Ala Asp Ser Phe
Ala Asp Tyr Ala
Ala Glu Gly Tyr
Ala Glu Tyr Gly
Ala Phe Asp Ser
Ala Phe Ser Asp
Ala Gly Glu Tyr
Ala Gly Tyr Glu
Ala His Asp Pro
Ala His Pro Asp
Ala Pro Asp His
Ala Pro His Asp
Ala Ser Asp Phe
Ala Ser Phe Asp
Ala Tyr Ala Asp
Ala Tyr Asp Ala
Ala Tyr Glu Gly
Ala Tyr Gly Glu
Asp Ala Ala Tyr
Asp Ala Phe Ser
Asp Ala His Pro
Asp Ala Pro His
Asp Ala Ser Phe
Asp Ala Tyr Ala
Asp Phe Ala Ser
Asp Phe Gly Thr
Asp Phe Ser Ala
Asp Phe Thr Gly
Asp Gly Phe Thr
Asp Gly Thr Phe
Asp His Ala Pro
Asp His Pro Ala
Asp Pro Ala His
Asp Pro His Ala
Asp Ser Ala Phe
Asp Ser Phe Ala
Asp Thr Phe Gly
Asp Thr Gly Phe
Asp Tyr Ala Ala
Glu Ala Gly Tyr
Glu Ala Tyr Gly
Glu Phe Gly Ser
Glu Phe Ser Gly
Glu Gly Ala Tyr
Glu Gly Phe Ser
Glu Gly His Pro
Glu Gly Pro His
Glu Gly Ser Phe
Glu Gly Tyr Ala
Glu His Gly Pro
Glu His Pro Gly
Glu Pro Gly His
Glu Pro His Gly
Glu Ser Phe Gly
Glu Ser Gly Phe
Glu Tyr Ala Gly
Glu Tyr Gly Ala
Phe Ala Asp Ser
Phe Ala Ser Asp
Phe Asp Ala Ser
Phe Asp Gly Thr
Phe Asp Ser Ala
Phe Asp Thr Gly
Phe Glu Gly Ser
Phe Glu Ser Gly
Phe Gly Asp Thr
Phe Gly Glu Ser
Phe Gly Ser Glu
Phe Gly Thr Asp
Phe Ser Ala Asp
Phe Ser Asp Ala
Phe Ser Glu Gly
Phe Ser Gly Glu
Phe Thr Asp Gly
Phe Thr Gly Asp
Gly Ala Glu Tyr
Gly Ala Tyr Glu
Gly Asp Phe Thr
Gly Asp Thr Phe
Gly Glu Ala Tyr
Gly Glu Phe Ser
Gly Glu His Pro
Gly Glu Pro His
Gly Glu Ser Phe
Gly Glu Tyr Ala
Gly Phe Asp Thr
Gly Phe Glu Ser
Gly Phe Ser Glu
Gly Phe Thr Asp
Gly His Glu Pro
Gly His Pro Glu
Gly Pro Glu His
Gly Pro His Glu
Gly Ser Glu Phe
Gly Ser Phe Glu
Gly Thr Asp Phe
Gly Thr Phe Asp
Gly Tyr Ala Glu
Gly Tyr Glu Ala
His Ala Asp Pro
His Ala Pro Asp
His Asp Ala Pro
His Asp Pro Ala
His Glu Gly Pro
His Glu Pro Gly
His Gly Glu Pro
His Gly Pro Glu
His Pro Ala Asp
His Pro Asp Ala
His Pro Glu Gly
His Pro Gly Glu
Met Ser Thr Thr
Met Thr Ser Thr
Met Thr Thr Ser
Pro Ala Asp His
Pro Ala His Asp
Pro Asp Ala His
Pro Asp His Ala
Pro Glu Gly His
Pro Glu His Gly
Pro Gly Glu His
Pro Gly His Glu
Pro His Ala Asp
Pro His Asp Ala
Pro His Glu Gly
Pro His Gly Glu
Ser Ala Asp Phe
Ser Ala Phe Asp
Ser Asp Ala Phe
Ser Asp Phe Ala
Ser Glu Phe Gly
Ser Glu Gly Phe
Ser Phe Ala Asp
Ser Phe Asp Ala
Ser Phe Glu Gly
Ser Phe Gly Glu
Ser Gly Glu Phe
Ser Gly Phe Glu
Ser Met Thr Thr
Ser Thr Met Thr
Ser Thr Thr Met
Thr Asp Phe Gly
Thr Asp Gly Phe
Thr Phe Asp Gly
Thr Phe Gly Asp
Thr Gly Asp Phe
Thr Gly Phe Asp
Thr Met Ser Thr
Thr Met Thr Ser
Thr Ser Met Thr
Thr Ser Thr Met
Thr Thr Met Ser
Thr Thr Ser Met
Tyr Ala Ala Asp
Tyr Ala Asp Ala
Tyr Ala Glu Gly
Tyr Ala Gly Glu
Tyr Asp Ala Ala
Tyr Glu Ala Gly
Tyr Glu Gly Ala
Tyr Gly Ala Glu
Tyr Gly Glu Ala
punaglandin 7
(+)-Cloprostenol methyl ester
8-Propanoylneosolaniol
6alpha,9-difluoro-11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 21-acetate
Radezolid
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D023303 - Oxazolidinones C254 - Anti-Infective Agent > C258 - Antibiotic
3-Quinolinecarboxamide, N-(1,3-benzodioxol-5-ylmethyl)-1,2-dihydro-7-methoxy-2-oxo-8-(pentyloxy)-
(S)-2-((S)-2-((S)-2-Amino-3-(1H-indol-3-yl)propanamido)-3-hydroxypropanamido)-3-phenylpropanoic acid
C23H26N4O5 (438.19031060000003)
Bis(trimethylsilyl) 2,3-bis[(trimethylsilyl)oxy]succinate
Sotrastaurin
C25H22N6O2 (438.18041519999997)
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor
XL335
C25H24F2N2O3 (438.17548980000004)
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent
N-[(Z)-2-[acetyl-(2-oxo-3-phenylpropyl)amino]-3-(7-methoxy-1,3-benzodioxol-5-yl)prop-1-enyl]acetamide
N-[2-(cyclopentylamino)-1-(4-fluorophenyl)-2-oxoethyl]-N-[(4-fluorophenyl)methyl]-1H-pyrazole-5-carboxamide
N-[2,5-diethoxy-4-[[2-(3-methoxyphenyl)-1-oxoethyl]amino]phenyl]-2-furancarboxamide
(2R,3R,3aS,9bS)-1-[cyclohexyl(oxo)methyl]-3-(hydroxymethyl)-6-oxo-7-(5-pyrimidinyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid
C23H26N4O5 (438.19031060000003)
(2S,3S,3aR,9bR)-1-[cyclohexyl(oxo)methyl]-3-(hydroxymethyl)-6-oxo-7-(5-pyrimidinyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid
C23H26N4O5 (438.19031060000003)
4-(2,3-Dihydro-1,4-benzodioxine-6-carbonyl)-1-[2-(dimethylamino)ethyl]-5-(3-methoxyphenyl)pyrrolidine-2,3-dione
alpha-D-GalNpAc-(1->3)-beta-D-GalpNAc-OMe
C17H30N2O11 (438.18495099999996)
A methyl glycoside that is N-acetyl-alpha-D-galactosaminyl-(1->3)-N-acetyl-beta-D-galactosamine in which the anomeric hydroxy group is replaced by methoxy.
alpha-D-GalNpAc-(1->3)-alpha-D-GalpNAc-OMe
C17H30N2O11 (438.18495099999996)
A methyl glycoside that is N-acetyl-alpha-D-galactosaminyl-(1->3)-N-acetyl-alpha-D-galactosamine in which the anomeric hydroxy group is replaced by methoxy.
13-[(acetyloxy)methyl]-12-hydroxy-9-methyl-5-methylidene-4-oxo-3,14-dioxatricyclo[7.4.1.0²,⁶]tetradecan-7-yl 2-(hydroxymethyl)but-2-enoate
(3r)-6-{[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-8-methoxy-3-{[(2r,6s)-6-methyloxan-2-yl]methyl}-3,4-dihydro-2-benzopyran-1-one
methyl (3as,4s,5s,10s,11ar)-5-(acetyloxy)-10-(hydroxymethyl)-3-methylidene-4-[(2-methylpropanoyl)oxy]-2-oxo-3ah,4h,5h,8h,9h,10h,11h,11ah-cyclodeca[b]furan-6-carboxylate
2,4-bis[(4-hydroxyphenyl)methyl]-5-methoxy-3-[(1e)-2-phenylethenyl]phenol
1-{3-acetyl-4-[(7-methoxy-2h-1,3-benzodioxol-5-yl)methyl]-7-phenyl-6-oxa-3,8-diazabicyclo[3.2.1]octan-8-yl}ethanone
3,12,15,16-tetrahydroxy-2,6,14,17-tetramethyl-4,11-dioxo-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-5-en-8-yl acetate
(1r,1's,5r,6's,8's)-8'-chloro-4-(diethylamino)-5-hydroxy-2',3'-dimethoxy-10'-methyl-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione
16-methoxy-14-oxapentacyclo[20.2.2.2¹⁰,¹³.1¹⁵,¹⁹.0²,⁷]nonacosa-1(25),2,4,6,10,12,15(27),16,18,22(26),23,28-dodecaene-5,24-diol
(2s)-2-({[(4s)-2-(2,3-dihydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl](hydroxy)methylidene}amino)-3-hydroxy-n-[4-(n-hydroxyacetamido)butyl]propanimidic acid
(8z,20z)-5-methoxy-14-oxapentacyclo[20.2.2.2¹⁰,¹³.1¹⁵,¹⁹.0²,⁷]nonacosa-2,4,6,8,11,15(27),16,18,20,23,25,28-dodecaene-16,24-diol
(1s,2r,3r,4s,7r,8s,9s,10s,12z,14r,17s)-2,7,10-trihydroxy-4,8,12,17-tetramethyl-5,16-dioxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-9-yl acetate
n-[3-(7-methoxy-2h-1,3-benzodioxol-5-yl)-2-[n-(2-oxo-3-phenylpropyl)acetamido]prop-1-en-1-yl]ethanimidic acid
15β-o-acetyl-14-hydroxyklaineanone
{"Ingredient_id": "HBIN001640","Ingredient_name": "15\u03b2-o-acetyl-14-hydroxyklaineanone","Alias": "NA","Ingredient_formula": "C22H30O9","Ingredient_Smile": "CC1C(C(C2C3(C(CC4C2(C1(C(C(=O)O4)OC(=O)C)O)C)C(=CC(=O)C3O)C)C)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "421","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5-methoxy-3-(2-phenyl-e-ethenyl)-2,4-bis(4-hydroxybenzyl)phenol
{"Ingredient_id": "HBIN011732","Ingredient_name": "5-methoxy-3-(2-phenyl-e-ethenyl)-2,4-bis(4-hydroxybenzyl)phenol","Alias": "NA","Ingredient_formula": "C29H26O4","Ingredient_Smile": "COC1=C(C(=C(C(=C1)O)CC2=CC=C(C=C2)O)C=CC3=CC=CC=C3)CC4=CC=C(C=C4)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14049","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5-Mpe-bis(hobz)phenol
{"Ingredient_id": "HBIN011828","Ingredient_name": "5-Mpe-bis(hobz)phenol","Alias": "2,4-bis[(4-hydroxyphenyl)methyl]-5-methoxy-3-(2-phenylvinyl)phenol; 2,4-bis(4-hydroxybenzyl)-5-methoxy-3-[(E)-2-phenylvinyl]phenol; 2,4-bis[(4-hydroxyphenyl)methyl]-5-methoxy-3-(2-phenylethenyl)phenol; 5-Methoxy-3-(2-phenylethenyl)-2,4-bis(4-hydroxybenzyl)phenol; 2,4-bis[(4-hydroxyphenyl)methyl]-5-methoxy-3-[(E)-2-phenylvinyl]phenol; 152383-83-0; 2,4-bis[(4-hydroxyphenyl)methyl]-5-methoxy-3-[(E)-2-phenylethenyl]phenol; 5-Methoxy-3-(2-phenyl-E-E-ethenyl)-2,4-bis(4-hydroxybenzyl) phenol; 2,4-bis(4-hydroxybenzyl)-5-methoxy-3-(2-phenylvinyl)phenol","Ingredient_formula": "C29H26O4","Ingredient_Smile": "COC1=C(C(=C(C(=C1)O)CC2=CC=C(C=C2)O)C=CC3=CC=CC=C3)CC4=CC=C(C=C4)O","Ingredient_weight": "438.51","OB_score": "11.32530743","CAS_id": "152383-83-0","SymMap_id": "SMIT09692","TCMID_id": "NA","TCMSP_id": "MOL008390","TCM_ID_id": "NA","PubChem_id": "5319481","DrugBank_id": "NA"}